In a first-in-world clinical trial, researchers at Sunnybrook Health Sciences Centre in Toronto, Canada, have demonstrated that magnetic resonance (MR)-guided
Home »
Comprehensive clinical sequencing opens door to the promise of precision medicine
St. Jude Children’s Research Hospital investigators have demonstrated that comprehensive genomic sequencing of all pediatric cancer patients is feasible and
Synthetic data boosts accuracy and speed of brain tumor surgery CDS
Credit: Michigan Medicine/Synthetaic Michigan Medicine was working toward a goal: to develop a decision support tool that would improve pathologists’
How much telehealth do patients need? Researchers weigh in
Researchers from West Virginia University have set out to determine the optimal frequency of telehealth appointments for patients with chronic
China approves inhaled CanSino vaccine for clinical trials
China’s drug authority has approved for clinical trials an inhaled COVID-19 vaccine co-developed by domestic firm CanSino Biologics, the company
AMIA has suggestions to build trust in AI clinical decision support
The American Medical Informatics Association has issued some new recommendations for how clinical decision support tools that adapt their algorithms as
Mid-term clinical trial results show similar outcomes in promising cell therapies for CLI
Mid-term results of the first clinical trial designed specifically to evaluate the safety and effectiveness of two cell therapies that
Cleveland Clinic leadership on patient input: 'We have a responsibility to stay curious'
The COVID-19 crisis has both complicated and spotlighted patient experience, with the safety of individuals sometimes at odds with their
Experts outline key challenges for assessing clinical efficacy of COVID-19 vaccines
Collaboration and standardised approaches for assessing different vaccine efficacy endpoints are key for meaningful comparison of different COVID-19 vaccine candidates
Clinical trial for AstraZeneca/Oxford Covid-19 vaccine has resumed in US: company
The clinical trial for the COVID-19 vaccine being developed by AstraZeneca and Britain’s University of Oxford has resumed in the